⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026

NSE

Lupin LimitedLUPIN

LUPIN₹2,277.8 1.36% today
Nifty Midcap 150

Lupin is a major pharma company strong in US generics and respiratory.

Key productsGenerics, inhalation, biosimilars, APIs; India branded.
GeographyUS, India, EMEA, APAC.
CompetitorsSun Pharma, Cipla, Dr Reddy's.

AI-generated overview — verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Rs 12 Per Share

ex 2025-07-25

Competitive landscape — the read

vs mapped peers
Institutional money is backing CIPLA hardest (+1,527.1 Cr net). LUPIN ranks #4 of 9 on flow (net buying +0 Cr). Filing momentum favours SUNPHARMA (+2). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1CIPLA+1,527.1 Cr39+1+1235
2MANKIND+445.9 Cr38
3ALKEM+103.5 Cr33-26
4LUPINThis+0 Cr4
5DRREDDY+0 Cr4+1632
6SUNPHARMA+0 Cr6+2+1134
7TORNTPHARM+0 Cr2
8ZYDUSLIFE+0 Cr1+1
9AUROPHARMA+0 Cr2

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — LUPIN day by day

  1. 2026-06-08FilingLupin Limited has informed the Exchange regarding a press release dated Jun 08, 2026, titled "Lupin CollaboratPress Release
  2. 2025-10-14BlockSELL · ₹11.6 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
  3. 2025-10-14BlockBUY · ₹11.6 CrGOLDMAN SACHS BANK EUROPE SE - ODI
  4. 2025-10-13BlockSELL · ₹16.2 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
  5. 2025-10-13BlockBUY · ₹16.2 CrGOLDMAN SACHS BANK EUROPE SE - ODI
  6. 2025-07-25ActionDividend - Rs 12 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 2
    Press ReleaseNeutral

    a press release dated Jun 08, 2026, titled "Lupin Collaborates with ERN for Luforbec® (beclometasone/formoterol) pMDI Launch in Spain".

    Source PDF →

Bulk & block deals

4 deals · 2025-10-13 → 2025-10-14

DateCounterpartyInvestor typeSideValue
2025-10-14GOLDMAN SACHS (SINGAPORE) PTE - ODIHNI / otherSELL₹11.6 Cr
2025-10-14GOLDMAN SACHS BANK EUROPE SE - ODIHNI / otherBUY₹11.6 Cr
2025-10-13GOLDMAN SACHS (SINGAPORE) PTE - ODIHNI / otherSELL₹16.2 Cr
2025-10-13GOLDMAN SACHS BANK EUROPE SE - ODIHNI / otherBUY₹16.2 Cr

4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on LUPIN

RSS News

0

No recent news.

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.